HHQ16 [2620471-66-9]

TargetMol Chemicals

HHQ16 [2620471-66-9]

16

Research Use Only

C30H48F2O4

510.7

HHQ16, an orally active derivative of Astragaloside IV, effectively reverses infarction-induced hypertrophy and heart failure by targeting and degrading lnc4012/lnc9456 and antagonizing their effects on G3BP2/NF-kappaB signaling [1].

C[C@]12[C@]3([C@]4([C@]5(C4)[C@@]([C@@H](O)C3)(C(C)(C)C(F)(F)CC5)[H])CC[C@]1(C)[C@]([C@@H](O)C2)([C@]6(C)O[C@H](C(C)(C)O)CC6)[H])[H]

-20°C

12352200